Total Payments
$102,125
2024 Payments
$1,362
Companies
22
Transactions
347
Medicare Patients
409
Medicare Billing
$40,270
Payment Breakdown by Category
Other$71,167 (69.7%)
Travel$16,244 (15.9%)
Consulting$7,943 (7.8%)
Food & Beverage$6,753 (6.6%)
Education$18.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,167 | 34 | 69.7% |
| Travel and Lodging | $16,244 | 33 | 15.9% |
| Consulting Fee | $7,943 | 4 | 7.8% |
| Food and Beverage | $6,753 | 271 | 6.6% |
| Education | $18.92 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $42,895 | 61 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $28,261 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18,672 | 33 | $0 (2024) |
| Allergan, Inc. | $9,128 | 35 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $527.33 | 27 | $0 (2020) |
| ABBVIE INC. | $396.64 | 30 | $0 (2024) |
| Indivior Inc. | $390.98 | 16 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $372.85 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $297.90 | 19 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $226.51 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,362 | 73 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($226.51) |
| 2023 | $890.24 | 52 | Indivior Inc. ($212.18) |
| 2022 | $1,434 | 6 | Janssen Pharmaceuticals, Inc ($1,283) |
| 2021 | $4,096 | 5 | Janssen Pharmaceuticals, Inc ($4,067) |
| 2020 | $2,774 | 10 | Janssen Pharmaceuticals, Inc ($2,640) |
| 2019 | $11,232 | 47 | Janssen Pharmaceuticals, Inc ($5,352) |
| 2018 | $32,636 | 76 | Alkermes, Inc. ($14,019) |
| 2017 | $47,702 | 78 | Alkermes, Inc. ($24,470) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CNS | ||||||
| 10/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CNS | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CNS | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neuropsychiatry | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 99 | 316 | $11,857 | $6,077 |
| 2022 | 1 | 95 | 436 | $15,947 | $8,824 |
| 2021 | 1 | 83 | 542 | $18,167 | $10,726 |
| 2020 | 1 | 132 | 452 | $23,248 | $14,642 |
Total Patients
409
Total Services
1,746
Medicare Billing
$40,270
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 54 | 208 | $8,137 | $4,233 | 52.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 108 | $3,720 | $1,844 | 49.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 70 | 410 | $14,457 | $8,768 | 60.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 25 | 26 | $1,490 | $55.80 | 3.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 83 | 542 | $18,167 | $10,726 | 59.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 346 | $17,501 | $12,282 | 70.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 54 | 106 | $5,748 | $2,360 | 41.1% |
About Dr. Benjamin Roy, M.D
Dr. Benjamin Roy, M.D is a Psychiatry healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013021492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Roy, M.D has received a total of $102,125 in payments from pharmaceutical and medical device companies, with $1,362 received in 2024. These payments were reported across 347 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,167).
As a Medicare-enrolled provider, Roy has provided services to 409 Medicare beneficiaries, totaling 1,746 services with total Medicare billing of $40,270. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbus, GA
- Active Since 08/19/2006
- Last Updated 05/23/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1013021492
Products in Payments
- Aristada 441 mg (Drug) $38,488
- REXULTI (Drug) $16,518
- INVEGA SUSTENNA (Drug) $14,059
- ABILIFY MAINTENA (Drug) $11,767
- VRAYLAR (Drug) $9,525
- INVEGA TRINZA (Drug) $4,604
- ARISTADA (Drug) $4,407
- LATUDA (Drug) $527.33
- PERSERIS (Drug) $390.98
- CAPLYTA (Drug) $385.08
- INGREZZA (Drug) $372.85
- UZEDY (Drug) $172.03
- Austedo XR (Drug) $125.87
- Trintellix (Drug) $117.04
- FANAPT (Drug) $99.79
- NUEDEXTA (Drug) $95.63
- Auvelity (Drug) $53.86
- NUPLAZID (Drug) $53.25
- Fanapt (Drug) $41.91
- COBENFY (Drug) $41.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbus
Fred Romeo, Md, MD
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Michael Saribalas
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Kevin Ware, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Peter Zafirides, Md, MD
Psychiatry — Payments: $127,832
Psychiatry $127,832
Barbara Gracious, M.d, M.D
Psychiatry — Payments: $58,986
Psychiatry $58,986
Dr. Pavan Dontineni, M.d, M.D
Psychiatry — Payments: $32,829
Psychiatry $32,829